Filing Flows › Privia Health Group (PRVA) › Guidance & outlook
Privia Health Group (PRVA) guidance and outlook
Privia Health Group (PRVA) raised its guidance on Nov 5, 2026: Revenue $2.1B for FY2026; EBITDA $126M for FY2026. Privia Health Group's 10-Q filed Nov 5, 2026 makes 25 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $2.1B | reaffirmed |
| EBITDA | FY2026 | $126M | reaffirmed |
From the earnings release filed Nov 5, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 5, 2026
- We have national committees that distribute quality guidance, and we employ Chief Medical Officers who provide clinical oversight and direction over the clinical affairs of the Owned Medical Groups.
- As a result of receiving these rate inflators and enhancements, if we continue to be successful in expanding our provider base, we expect revenue will grow year-over-year in absolute dollars.
- We intend to increase our provider base in existing and new markets by adding new practices and assisting our existing practices with recruiting new providers, using our in-market and national sales and marketing teams.
- As we add providers to the Privia Platform, we expect them to contribute incremental economics as we leverage our existing brand and infrastructure, both at the corporate and in-market levels.
- We believe our continued success in growing the visibility of the Privia brand will result in increased patient panels per provider and contribute incremental revenue in both FFS and VBC for our practices.
- To do so, we will need to continue enhancing our VBC capabilities and executing on initiatives to deliver next generation access, superior quality metrics and lower cost of care.
- Our ability to maintain or improve pricing levels in our contracts with payers and patient volume for our providers will impact our results of operations.
- As we grow our provider base, we also expect to increase our total number of attributed patients in existing and new markets.
- In addition, we intend to increase the risk levels of our value-based programs as we seek a higher revenue opportunity on a per patient basis over time.
- We expect to continue focusing on long-term growth through investments in our sales and marketing, our technology-enabled platform, and our operations.
- In addition, as we continue our efforts to move markets toward VBC, we expect to continue making additional investments in operations for an expanded suite of clinical capabilities to manage our patient population.
- We believe that growth in the number of Implemented Providers is a key indicator of the performance of our business and expected revenue growth.
Privia Health Group's latest quarter
Privia Health Group, Q3 2026: revenue $657M (+13% year over year), operating margin 3.1%, net earnings $13.5M, operating cash flow $28.9M. The chart follows the revenue to costs, profit and cash.
Questions
Did Privia Health Group raise or lower its guidance?
Privia Health Group (PRVA) raised its guidance on Nov 5, 2026: Revenue $2.1B for FY2026; EBITDA $126M for FY2026.
What does Privia Health Group expect?
We have national committees that distribute quality guidance, and we employ Chief Medical Officers who provide clinical oversight and direction over the clinical affairs of the Owned Medical Groups. As a result of receiving these rate inflators and enhancements, if we continue to be successful in expanding our provider base, we expect revenue will grow year-over-year in absolute dollars. We intend to increase our provider base in existing and new markets by adding new practices and assisting our existing practices with recruiting new providers, using our in-market and national sales and market
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.